COVID-19 Vaccine COVAXIN’s Animal Trial Gets Robust Immune Responses

In animal studies, the COVID-19 vaccine candidate, COVAXIN has shown positive efficacy and generated robust immune responses, said Bharat Biotech International Limited. The vaccine COVAXIN developed by the Indian Council of Medical Research and Bharat Biotech is tested at 12 institutes across India.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.